53 results on '"Lorand-Metze, Irene"'
Search Results
2. Comment on “Large Language Models in Ophthalmology Scientific Writing: Ethical Considerations Blurred Lines or Not at All?”
3. Bibliographic research with ChatGPT may be misleading: The problem of hallucination
4. LINFOMA/LEUKEMIA DE BURKITT APRESENTANDO SUBCLONES
5. Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels
6. Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
7. Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
8. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
9. Part 2: Myelodysplastic syndromes – classification systems
10. Guidelines on myelodysplastic syndromes: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
11. IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes
12. Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
13. Chronic Lymphocytic Leukemia in Brazil: Analysis of 1903 Cases
14. The World Health Organisation classification of myelodysplastic syndromes contains prognostically relevant information beyond the prognostic scores IPSS-R or WPSS
15. Erratum to “Diagnosis and treatment of chronic lymphocytic leukemia: Recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia” [Rev Bras Hematol Hemoter. 2016;38(4):346–357]
16. Monocyte phenotypic aberrancies are an unfavorable prognostic factor in patients with myelodysplastic syndromes and low IPSS-R scores
17. Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
18. Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
19. Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms
20. Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil
21. Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else
22. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
23. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells
24. Quantifying loss of CD34+ cells collected by apheresis after processing for freezing and post-thaw
25. Downregulation of IRS2 in myelodysplastic syndrome: A possible role in impaired hematopoietic cell differentiation
26. Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias
27. Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
28. 141-P: Major histocompatibility complex genes as marker of predisposition to acutes leukemias
29. A importância da integração de dados do diagnóstico das hemopatias
30. The importance of the detection of MRD at the end of induction chemotherapy in childhood ALL
31. Risk assessment for multiple myeloma: preliminary results of the brazilian myeloma study group
32. The influence of storage and leukocyte depletion on the antigen densities of FY1, FY2, MNS3 and MNS4 measured by flow cytometry
33. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk
34. Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndrome
35. Expressions of the VLA-4, LFA-1 and Mac-1 integrins in eosinophil migration in a case of chronic eosinophilic leukaemia
36. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders
37. Síndrome mielodisplásica na infância
38. Síndromes mielodisplásicas, sua importância no nosso meio
39. Contribuição da citometria de fluxo para o diagnóstico e prognóstico das síndromes mielodisplásicas
40. Interaction of clinical, genetic and molecular features in chronic lymphocytic leukemia
41. Large infiltration of chronic lymphocytic leukemia in the mandibular region
42. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes
43. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications
44. Clinical features and chromosomal abnormality in Myelodysplastic Syndrome of the Refractory Anaemia Subtype
45. P53 gene deletion in multiple myeloma
46. Nódulos linfóides medulares
47. O tratamento da Leucemia Mielóide Aguda no Brasil: o que já progredimos e o que podemos melhorar
48. Expression of p190 BCR-ABL fusion gene in a patient with chronic myeloid leukemia
49. The Brazilian pediatric myelodysplastic cooperative group strategies: are they relevant to improve educational approach and correct diagnosis?
50. Bone marrow lymphoid aggregates in myelodysplastic syndromes: incidence, immunomorphological characteristics and correlation with clinical features and survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.